Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „trial“
Suchtreffer
Begriffe & Kennungen
Abilify · 4.5 · Quinidine and other CYP2D6 inhibitors In a clinical trial in healthy subjects, a strong inhibitor of CYP2D6 (q
Eintrag öffnenAbilify · 4.5 · Quinidine and other CYP2D6 inhibitors In a clinical trial in healthy subjects, a strong inhibitor of CYP2D6 (q
Eintrag öffnenAbilify · 4.5 · Quinidine and other CYP2D6 inhibitors In a clinical trial of oral aripiprazole in healthy subjects, a strong i
Eintrag öffnenAbilify · 4.8 · 51 Prolactin In clinical trials for the approved indications and post-marketing, both increase and decrease in
Eintrag öffnenAbilify · 4.8 · Akathisia In placebo-controlled trials, the incidence of akathisia in bipolar patients was 12.1 % with aripipr
Eintrag öffnenAbilify · 4.8 · Akathisia In placebo-controlled trials, the incidence of akathisia in bipolar patients was 12.1 % with aripipr
Eintrag öffnenAbilify · 4.8 · Akathisia In placebo-controlled trials, the incidence of akathisia in bipolar patients was 12.1 % with aripipr
Eintrag öffnenAbilify · 4.8 · Akathisia In placebo-controlled trials, the incidence of akathisia in bipolar patients was 12.1 % with aripipr
Eintrag öffnenAbilify · 4.8 · Extrapyramidal symptoms (EPS) Schizophrenia: in a long-term 52-week controlled trial, aripiprazole-treated pat
Eintrag öffnenAbilify · 4.8 · Extrapyramidal symptoms (EPS) Schizophrenia: in a long-term 52-week controlled trial, aripiprazole-treated pat
Eintrag öffnenAbilify · 4.8 · Extrapyramidal symptoms (EPS) Schizophrenia: in a long-term 52-week controlled trial, aripiprazole-treated pat
Eintrag öffnenAbilify · 4.8 · Extrapyramidal symptoms (EPS) Schizophrenia: in a long-term 52-week controlled trial, aripiprazole-treated pat
Eintrag öffnenAbilify · 4.8 · Manic episodes in Bipolar I Disorder: in a 12-week controlled trial, the incidence of EPS was 23.5 % for aripi
Eintrag öffnenAbilify · 4.8 · Manic episodes in Bipolar I Disorder: in a 12-week controlled trial, the incidence of EPS was 23.5 % for aripi
Eintrag öffnenAbilify · 4.8 · Manic episodes in Bipolar I Disorder: in a 12-week controlled trial, the incidence of EPS was 23.5 % for aripi
Eintrag öffnenAbilify · 4.8 · Manic episodes in Bipolar I Disorder: in a 12-week controlled trial, the incidence of EPS was 23.5 % for aripi
Eintrag öffnenAbilify · 4.8 · Prolactin In clinical trials for the approved indications and post-marketing, both increase and decrease in se
Eintrag öffnenAbilify · 4.8 · Prolactin In clinical trials for the approved indications and post-marketing, both increase and decrease in se
Eintrag öffnenAbilify · 4.8 · Prolactin In clinical trials for the approved indications and post-marketing, both increase and decrease in se
Eintrag öffnenAbilify · 4.8 · Schizophrenia in adolescents aged 15 years and older In a short-term placebo-controlled clinical trial involvi
Eintrag öffnen